Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18566376rdf:typepubmed:Citationlld:pubmed
pubmed-article:18566376lifeskim:mentionsumls-concept:C0041296lld:lifeskim
pubmed-article:18566376lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:18566376lifeskim:mentionsumls-concept:C0011065lld:lifeskim
pubmed-article:18566376lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:18566376lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:18566376lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:18566376lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:18566376lifeskim:mentionsumls-concept:C2728259lld:lifeskim
pubmed-article:18566376pubmed:issue1lld:pubmed
pubmed-article:18566376pubmed:dateCreated2008-6-20lld:pubmed
pubmed-article:18566376pubmed:abstractTextProtective immunity against Mycobacterium tuberculosis requires the generation of cell-mediated immunity. We investigated the expression and role of programmed death 1 (PD-1) and its ligands, molecules known to modulate T cell activation, in the regulation of IFN-gamma production and lytic degranulation during human tuberculosis. We demonstrated that specific Ag-stimulation increased CD3+PD-1+ lymphocytes in peripheral blood and pleural fluid from tuberculosis patients in direct correlation with IFN-gamma production from these individuals. Moreover, M. tuberculosis-induced IFN-gamma participated in the up-regulation of PD-1 expression. Blockage of PD-1 or PD-1 and its ligands (PD-Ls: PD-L1, PD-L2) enhanced the specific degranulation of CD8+ T cells and the percentage of specific IFN-gamma-producing lymphocytes against the pathogen, demonstrating that the PD-1:PD-Ls pathway inhibits T cell effector functions during active M. tuberculosis infection. Furthermore, the simultaneous blockage of the inhibitory receptor PD-1 together with the activation of the costimulatory protein signaling lymphocytic activation molecule led to the promotion of protective IFN-gamma responses to M. tuberculosis, even in patients with weak cell-mediated immunity against the bacteria. Together, we demonstrated that PD-1 interferes with T cell effector functions against M. tuberculosis, suggesting that PD-1 has a key regulatory role during the immune response of the host to the pathogen.lld:pubmed
pubmed-article:18566376pubmed:languageenglld:pubmed
pubmed-article:18566376pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18566376pubmed:statusMEDLINElld:pubmed
pubmed-article:18566376pubmed:monthJullld:pubmed
pubmed-article:18566376pubmed:issn0022-1767lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:ChuluyanH...lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:GarcíaVerónic...lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:AbbateEduardo...lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:PasquinelliVi...lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:QuirogaMaría...lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:MartínezGusta...lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:MusellaRosa...lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:JuradoJavier...lld:pubmed
pubmed-article:18566376pubmed:authorpubmed-author:AlvarezIvana...lld:pubmed
pubmed-article:18566376pubmed:issnTypePrintlld:pubmed
pubmed-article:18566376pubmed:day1lld:pubmed
pubmed-article:18566376pubmed:volume181lld:pubmed
pubmed-article:18566376pubmed:ownerNLMlld:pubmed
pubmed-article:18566376pubmed:authorsCompleteYlld:pubmed
pubmed-article:18566376pubmed:pagination116-25lld:pubmed
pubmed-article:18566376pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:meshHeadingpubmed-meshheading:18566376...lld:pubmed
pubmed-article:18566376pubmed:year2008lld:pubmed
pubmed-article:18566376pubmed:articleTitleProgrammed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis.lld:pubmed
pubmed-article:18566376pubmed:affiliationDepartment of Biological Chemistry, School of Sciences, University of Buenos Aires, Buenos Aires, Argentina.lld:pubmed
pubmed-article:18566376pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18566376pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5133entrezgene:pubmedpubmed-article:18566376lld:entrezgene
entrez-gene:29126entrezgene:pubmedpubmed-article:18566376lld:entrezgene
entrez-gene:80380entrezgene:pubmedpubmed-article:18566376lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18566376lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18566376lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18566376lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18566376lld:pubmed